February 24, 2025
RegMed Investors’ (RMi) pre-open: Bought up on Monday after shot down on Friday
February 21, 2025
RegMed Investors’ (RMi) pre-open: think speculative behavior in this current market and sector
February 20, 2025
RegMed Investors’ (RMi) pre-open: back into econs and some slippage?
February 18, 2025
RegMed Investors’ (RMi) pre-open: What’s keeping the cell and gene therapy sector up/positive?
February 12, 2025
RegMed Investors’ (RMi) pre-open: I’d be nibbling as traders are on watching to pick
February 11, 2025
RegMed Investors’ (RMi) pre-open: headwinds or lack of headroom
February 10, 2025
RegMed Investors’ (RMi) pre-open: a volatile week ahead
February 7, 2025
RegMed Investors’ (RMi) pre-open: econ session again, payroll report
February 5, 2025
RegMed Investors’ (RMi) pre-open: Hang on
February 4, 2025
RegMed Investors’ (RMi) pre-open: coming off of a volatile trading session to another?
January 30, 2025
RegMed Investors’ (RMi) pre-open: ongoing rocky week, further erosion of pricing or some valuation bursts?
January 29, 2025
RegMed Investors’ (RMi) pre-open: econ day
January 28, 2025
RegMed Investors’ (RMi) pre-open: The Strange Case of Dr. Jekyll and Mr. Hyde
January 27, 2025
RegMed Investors’ (RMi) pre-open: watchout below, AI driving down today’s market
January 24, 2025
RegMed Investors’ (RMi) pre-open: new records pushing risk higher
January 23, 2025
RegMed Investors’ (RMi) pre-open: Threats perceived
January 22, 2025
RegMed Investors’ (RMi) pre-open: pre-emptive pardon your portfolio
January 21, 2025
RegMed Investors’ (RMi) pre-open: Post Inauguration, a new barometer
January 15, 2025
RegMed Investors’ (RMi) pre-open: more economics
January 14, 2025
RegMed Investors’ (RMi) pre-open: get it up, futures are higher
January 13, 2025
RegMed Investors’ (RMi) pre-open: Rollover Breathe, gotta see something today
January 10, 2025
RegMed Investors’ (RMi) pre-open: snap, crackle or a pop?
January 8, 2025
RegMed Investors’ (RMi) pre-open: calibrate
January 7, 2025
RegMed Investors’ (RMi) pre-open: expectation versus reality
January 6, 2025
RegMed Investors’ (RMi) pre-open: tools of 2025, headwinds and operation budgets
2 hours 22 min ago
RMi Research note: Sanofi (SAN-PA) has frozen R&D investment decisions in the U.K.
8 hours 17 min ago
RegMed Investors’ (RMi) pre-open: Support is TBD
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.